visible = false, 3500)" x-show="visible" x-cloak role="status" aria-live="polite">
Scanner membership is locked
Upgrade to Pro to explore full scanner membership and live in-scan status.
Dollar Volume 50D
$80.19M
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%?
The Motley Fool · 2026-09-01
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire Inc. · 2026-02-19
Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight
GlobeNewswire Inc. · 2025-08-28
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc. · 2025-07-14
Pro
Upgrade to unlock full access
- All scanner results, no caps
- Sorting and ranking controls
- Signal history and performance
- Premium stock data
Start 30 days free